FDA Drug recall D-407-2013
Sodium Bicarbonate Injection, all strengths and all presentations including: a) Sodium Bicarb 4.2% 5 mL PF, b) Sodium Bicarb 8.4% 50 mL SDV…
- FDA Drug
- Class II
- terminated
- Published 2013-05-22
On 2013-05-22 the FDA classified a Class II recall of Sodium Bicarbonate Injection, all strengths and all presentations including: a) Sodium Bicarb 4.2% 5 mL PF, b) Sodium Bicarb 8.4% 50 mL SDV… by Fvs Holdings Dba Green Valley Drugs, citing lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associate….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-407-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-04-10 |
| Published | 2013-05-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Fvs Holdings Dba Green Valley Drugs |
| Distribution | US |
Product
Sodium Bicarbonate Injection, all strengths and all presentations including: a) Sodium Bicarb 4.2% 5 mL PF, b) Sodium Bicarb 8.4% 50 mL SDV, c) Sodium Bicarbonate 8.4%, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
Reason
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Identifiers
| code_info | Lot #: Sodium Bicarb 4.2% 5 mL PF: 130123150AE, Exp 4/23/2013; b) Sodium Bicarb 8.4% 50 mL SDV: 20130315-L, Exp 6/15/20…Lot #: Sodium Bicarb 4.2% 5 mL PF: 130123150AE, Exp 4/23/2013; b) Sodium Bicarb 8.4% 50 mL SDV: 20130315-L, Exp 6/15/2013; c) Sodium Bicarbonate 8.4%: 20130117-D, Exp 4/17/2013; 20130117-E, Exp 4/17/2013; 20130117-F, Exp 4/17/2013; 20130121-B, Exp 4/21/2013; 20130121-C, Exp 4/21/2013; 20130121-D, Exp 4/21/2013; 20130121-E, Exp 4/21/2013; 20130121-F, Exp 4/21/2013; 20130121-H, Exp 4/21/2013; 20130121-I, Exp 4/21/2013; 20130121-J, Exp 4/21/2013; 20130121-K, Exp 4/21/2013; 20130124-D, Exp 4/24/2013; 20130124-E, Exp 4/24/2013; 20130129-B, Exp 4/29/2013; 20130129-C, Exp 4/29/2013; 20130129-D, Exp 4/29/2013; 20130129-K, Exp 4/29/2013; 20130129-L, Exp 4/29/2013; 20130129-M, Exp 4/29/2013; 20130131-I, Exp 4/30/2013; 20130131-J, Exp 4/30/2013; 20130131-K, Exp 4/30/2013; 20130201-B, Exp 5/1/2013; 20130201-C, Exp 5/1/2013; 20130211-A, Exp 5/11/2013; 20130211-B, Exp 5/11/2013; 20130211-C, Exp 5/11/2013; 20130211-D, Exp 5/11/2013; 20130211-E, Exp 5/11/2013; 20130211-F, Exp 5/11/2013; 2013021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-407-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.